Pharming PHAR
NASDAQ PHAR
$9.65 -0.10 (-1.03%)
As of: Oct 21, 2026 · 2:25 PM EDT

Pharming (PHAR) Shares Repurchased (2024)

Updated

Analysis

Pharming (PHAR) Shares Repurchased (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 1.60 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 221.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 9.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 757.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.20 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 355.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Pharming 664.67 Mn -129.70 Mn 141.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -134.92 Mn
API Access

Pharming Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=PHAR&period=max&api_key=YOUR_API_KEY